Exact Mass: 335.2187448

Exact Mass Matches: 335.2187448

Found 296 metabolites which its exact mass value is equals to given mass value 335.2187448, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Senecionine

(1,6)Dioxacyclododecino(2,3,4-gh)pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-, (3Z,5R,6R,14aR,14bR)-

C18H25NO5 (335.173264)


Senecionine is a pyrrolizidine alkaloid isolated from the plant species of the genus Senecio. It has a role as a plant metabolite. It is a lactone, a pyrrolizidine alkaloid and a tertiary alcohol. It is functionally related to a senecionan. It is a conjugate base of a senecionine(1+). Senecionine is a natural product found in Dorobaea pimpinellifolia, Crotalaria micans, and other organisms with data available. Senecionine is an organic compound with the chemical formula C18H25NO5. It is classified as a pyrrolizidine alkaloid. See also: Petasites hybridus root (part of); Tussilago farfara flower (part of); Tussilago farfara leaf (part of). A pyrrolizidine alkaloid isolated from the plant species of the genus Senecio. D000970 - Antineoplastic Agents Annotation level-1 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2251 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 122 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 102 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 142 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 152 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 162 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 172 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 132 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 112 [Raw Data] CB082a_Senecionine_pos_40eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_10eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_30eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_20eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_50eV_CB000034.txt Senecionine (Senecionan-11,16-dione, 12-hydroxy-) is a pyrrolizidine alkaloid could be isolated from Senecio vulgaris. Senecionine decreases the activities of glutathione S-transferase, aminopyrine demethylase and arylhydrocarbon hydroxylase (AHH)[1][2][3]. Senecionine (Senecionan-11,16-dione, 12-hydroxy-) is a pyrrolizidine alkaloid could be isolated from Senecio vulgaris. Senecionine decreases the activities of glutathione S-transferase, aminopyrine demethylase and arylhydrocarbon hydroxylase (AHH)[1][2][3].

   

Hydroxychloroquine

7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline

C18H26ClN3O (335.1764296)


Hydroxychloroquine is only found in individuals that have used or taken this drug. It is a chemotherapeutic agent that acts against erythrocytic forms of malarial parasites.Although the exact mechanism of action is unknown, it may be based on ability of hydroxychloroquine to bind to and alter DNA. Hydroxychloroquine has also has been found to be taken up into the acidic food vacuoles of the parasite in the erythrocyte. This increases the pH of the acid vesicles, interfering with vesicle functions and possibly inhibiting phospholipid metabolism. In suppressive treatment, hydroxychloroquine inhibits the erythrocytic stage of development of plasmodia. In acute attacks of malaria, it interrupts erythrocytic schizogony of the parasite. Its ability to concentrate in parasitized erythrocytes may account for their selective toxicity against the erythrocytic stages of plasmodial infection. As an antirheumatic, hydroxychloroquine is thought to act as a mild immunosuppressant, inhibiting the production of rheumatoid factor and acute phase reactants. It also accumulates in white blood cells, stabilizing lysosomal membranes and inhibiting the activity of many enzymes, including collagenase and the proteases that cause cartilage breakdown. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Senecivernine

21-Norsenecionan-11,16-dione, 12-hydroxy-14-methyl-, (12zeta,13zeta)-

C18H25NO5 (335.173264)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2276

   

Ankorine

Ankorine

C19H29NO4 (335.20964740000005)


A pyridoisoquinoline that is 1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline which is substituted at positions 2, 3, and 8 by 2-hydroxyethyl, ethyl, and hydroxy groups, respectively, and by methoxy groups at positions 9 and 10 (the 2R,3R,11bS stereoisomer). It is a benzo[a]quinolizidine alkaloid isolated from the Indian medicinal plant Alangium lamarckii.

   

Triangularine

6-Angelyl-9-sarracinylretronecine

C18H25NO5 (335.173264)


   

Lobelanine

2-[(2S,6R)-1-methyl-6-(2-oxo-2-phenyl-ethyl)piperidin-2-yl]-1-phenyl-ethanone

C22H25NO2 (335.188519)


Lobelanine is a member of acetophenones. Lobelanine is a natural product found in Lobelia sessilifolia, Lobelia inflata, and other organisms with data available. Lobelanine (8,10-Diphenyllobelidione) is a chemical precursor for the biosynthesis of Lobeline. Lobeline is a partial nicotinic agonist and is used as a smoking cessation agent[1][2]. Lobelanine (8,10-Diphenyllobelidione) is a chemical precursor for the biosynthesis of Lobeline. Lobeline is a partial nicotinic agonist and is used as a smoking cessation agent[1][2].

   

Cetrimide

Tetradecyl trimethyl ammonium bromide

C17H38N. Br (335.2187448)


Same as: D02164

   

N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide

(Z,2Z)-N-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylpropa-2-enimidic acid

C22H25NO2 (335.188519)


N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide is found in fruits. N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide is an alkaloid from the leaves of Aegle marmelos (bael fruit

   

9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate

[(4Z,6E,10Z,13Z)-1-carboxynonadeca-4,6,10,13-tetraen-8-yl]peroxy

C20H31O4 (335.2222226)


This compound belongs to the family of Hydroperoxy Fatty Acids. These are fatty acids contaning a hydroperoxide group attached to the chain.

   

11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate

[(4Z,7Z,11E,13Z)-1-carboxynonadeca-4,7,11,13-tetraen-10-yl]peroxy

C20H31O4 (335.2222226)


This compound belongs to the family of Hydroperoxy Fatty Acids. These are fatty acids contaning a hydroperoxide group attached to the chain.

   

Integerrimine

4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H25NO5 (335.173264)


   

N-Dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate

N,N-Dimethyl-N-(3-sulphopropyl)-1-dodecanaminium hydroxide inner salt

C17H37NO3S (335.2494012)


D013501 - Surface-Active Agents > D003902 - Detergents

   

2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone

2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

C22H25NO2 (335.188519)


   

Alkaloid A

{1-[(2-methylbut-2-enoyl)oxy]-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl}methyl 2-(hydroxymethyl)but-2-enoic acid

C18H25NO5 (335.173264)


   

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

C22H25NO2 (335.188519)


   
   
   
   
   

Rigidiusculamide D

Rigidiusculamide D

C18H25NO5 (335.173264)


   
   
   
   
   
   

JWH-250

2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone

C22H25NO2 (335.188519)


   
   
   
   

Maybridge2_000465

Maybridge2_000465

C22H29N3 (335.2361354)


   
   

MBP146-78

Pyridine, 4-[2-(4-fluorophenyl)-5-(1-methyl-4-piperidinyl)-1H-pyrrol-3-yl]-

C21H22FN3 (335.1797664)


   
   

3-Deoxy-3-methylaminoxylose-1,2-O-Isopropylidene, N-Ac, 5-benzyl

3-Deoxy-3-methylaminoxylose-1,2-O-Isopropylidene, N-Ac, 5-benzyl

C18H25NO5 (335.173264)


   

3,7-dimethoxy-2-methyl-5-octanyl-5,6,7,8-tetrahydroquinoline-4(1H)-one|chamaedrone

3,7-dimethoxy-2-methyl-5-octanyl-5,6,7,8-tetrahydroquinoline-4(1H)-one|chamaedrone

C20H33NO3 (335.2460308000001)


   

3-ethyl-2-(2-hydroxy-ethyl)-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-11-ol|Ankorin

3-ethyl-2-(2-hydroxy-ethyl)-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-11-ol|Ankorin

C19H29NO4 (335.20964740000005)


   

7-Senecioyl-9-sarracinoyl retronecine|7-senecioyl-9-sarracinylretronecine

7-Senecioyl-9-sarracinoyl retronecine|7-senecioyl-9-sarracinylretronecine

C18H25NO5 (335.173264)


   
   
   
   
   
   

Perforine

Perforine

C18H25NO5 (335.173264)


Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids; Origin: Plant

   

greenwayodendrin-3-one

greenwayodendrin-3-one

C23H29NO (335.2249024)


   

convolinine|N-hydroxyethylconvolvine

convolinine|N-hydroxyethylconvolvine

C18H25NO5 (335.173264)


   
   

11-hydroxy-4,12-dimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

11-hydroxy-4,12-dimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

C19H29NO2S (335.19188940000004)


   
   

(-)-4,4-Diphenyl-6-pyrrolidino-heptan-3-on|(-)-4,4-diphenyl-6-pyrrolidino-heptan-3-one

(-)-4,4-Diphenyl-6-pyrrolidino-heptan-3-on|(-)-4,4-diphenyl-6-pyrrolidino-heptan-3-one

C23H29NO (335.2249024)


   
   
   
   
   

4-Acetoxy-1,3,5,6-tetramethoxy-2-(N-methylacetylamino)hexane

4-Acetoxy-1,3,5,6-tetramethoxy-2-(N-methylacetylamino)hexane

C15H29NO7 (335.19439239999997)


   

2-(1-methyl-6-phenacylpiperidin-2-yl)-1-phenylethanone

2-(1-methyl-6-phenacylpiperidin-2-yl)-1-phenylethanone

C22H25NO2 (335.188519)


   
   

N3-Ac,N8-Me,10-deoxy-搂脦-(2-Hydroxy-4-oxodecanoyl)histidine

N3-Ac,N8-Me,10-deoxy-搂脦-(2-Hydroxy-4-oxodecanoyl)histidine

C18H29N3O3 (335.22088040000006)


   

3alpha-hydroxy-6beta-(3-hydroxy-2-methyl-3-phenylpropionyloxy)-7beta-hydroxytropane

3alpha-hydroxy-6beta-(3-hydroxy-2-methyl-3-phenylpropionyloxy)-7beta-hydroxytropane

C18H25NO5 (335.173264)


   
   
   
   
   
   
   
   
   

Rev 5901

α-pentyl-3-(2-quinolinylmethoxy)-benzenemethanol

C22H25NO2 (335.188519)


   
   
   
   
   

Squalidin

(1,6)DIOXACYCLODODECINO(2,3,4-GH)PYRROLIZINE-2,7-DIONE, 3-ETHYLIDENE-3,4,5,6,9,11,13,14,14A,14B-DECAHYDRO-6-HYDROXY-5,6-DIMETHYL-, (3E,5R,6R,14AR,14BR)-

C18H25NO5 (335.173264)


Integerrimine is a macrolide. Integerrimine is a natural product found in Crotalaria micans, Tussilago farfara, and other organisms with data available. See also: Petasites hybridus root (part of). D000970 - Antineoplastic Agents

   

(E)-methyl 11-(5-carbamoyl-4-oxo-4H-pyran-2-yl)undec-10-enoate_120105

(E)-methyl 11-(5-carbamoyl-4-oxo-4H-pyran-2-yl)undec-10-enoate_120105

C18H25NO5 (335.173264)


   
   

hydroxychloroquine

hydroxychloroquine

C18H26ClN3O (335.1764296)


P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2741

   
   
   
   
   
   
   
   

JWH 201

2-(4-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone

C22H25NO2 (335.188519)


   
   

N-Cinnamoyl-p-prenyloxyphenethylamine

(2Z)-N-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylprop-2-enamide

C22H25NO2 (335.188519)


   

N-(2E,9Z-hexadecadienoyl)-homoserine lactone

N-(2E,9Z-hexadecadienoyl)-homoserine lactone

C20H33NO3 (335.2460308000001)


   

CEHC glycine

N-(5-[(2R)-6-Hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl]-propanoyl)-glycine

C18H25NO5 (335.173264)


   

4-(4-nitrophenethyl)piperazine-1-carboxylic acid tert butyl ester

4-(4-nitrophenethyl)piperazine-1-carboxylic acid tert butyl ester

C17H25N3O4 (335.184497)


   

4-(4-nitrobenzylamino)piperidine-1-carboxylic acid tert-butyl ester

4-(4-nitrobenzylamino)piperidine-1-carboxylic acid tert-butyl ester

C17H25N3O4 (335.184497)


   

(4-BENZYLOXY-BENZYL)-HYDRAZINE

(4-BENZYLOXY-BENZYL)-HYDRAZINE

C17H25N3O4 (335.184497)


   

(3R,4S)-tert-Butyl 3-(1-ethoxyethoxy)-2-oxo-4-phenylazetidine-1-carboxylate

(3R,4S)-tert-Butyl 3-(1-ethoxyethoxy)-2-oxo-4-phenylazetidine-1-carboxylate

C18H25NO5 (335.173264)


   
   

(2S,3S,4S)-2-METHYL-2-(CARBOXYCYCLOPROPYL)GLYCINE

(2S,3S,4S)-2-METHYL-2-(CARBOXYCYCLOPROPYL)GLYCINE

C18H25NO5 (335.173264)


   

Norpipanone

4,4-diphenyl-6-piperidin-1-ylhexan-3-one

C23H29NO (335.2249024)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   
   

2-N-BOC-8-METHOXY-2-METHYLAMINO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLICACID

2-N-BOC-8-METHOXY-2-METHYLAMINO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLICACID

C18H25NO5 (335.173264)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(2-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(2-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

C18H29N3O3 (335.22088040000006)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(4-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(4-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

C18H29N3O3 (335.22088040000006)


   

(3S,4S)-BENZYL 3-AMINO-4-((TERT-BUTOXYCARBONYL)AMINO)PYRROLIDINE-1-CARBOXYLATE

(3S,4S)-BENZYL 3-AMINO-4-((TERT-BUTOXYCARBONYL)AMINO)PYRROLIDINE-1-CARBOXYLATE

C17H25N3O4 (335.184497)


   

4-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]oxymethyl]benzoic acid

4-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]oxymethyl]benzoic acid

C18H25NO5 (335.173264)


   
   

N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

C20H25N5 (335.210985)


   

3-KETO-DIHYDROSPHINGOSINE HCL

3-KETO-DIHYDROSPHINGOSINE HCL

C18H38ClNO2 (335.2590918)


   

Droprenilamine

Droprenilamine

C24H33N (335.26128580000005)


C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

   

2-((tert-Butyldimethylsilyloxy)methyl)-6-(trimethylsilyl)furo[3,2-b]pyridine

2-((tert-Butyldimethylsilyloxy)methyl)-6-(trimethylsilyl)furo[3,2-b]pyridine

C17H29NO2Si2 (335.1736734)


   

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-{2-[(trimethylsilyl)oxy]propan-2-yl}pyridine

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-{2-[(trimethylsilyl)oxy]propan-2-yl}pyridine

C17H30BNO3Si (335.20878999999996)


   

3-BENZYLOXY-1-TERT-BUTOXYCARBONYLAMINO-CYCLOPENTANECARBOXYLIC ACID

3-BENZYLOXY-1-TERT-BUTOXYCARBONYLAMINO-CYCLOPENTANECARBOXYLIC ACID

C18H25NO5 (335.173264)


   

N,N,N-Tributyl-1-pentanaminium bromide

N,N,N-Tributyl-1-pentanaminium bromide

C17H38BrN (335.2187448)


   

1-Deoxy-1-[methyl(nonanoyl)amino]-D-glucitol

1-Deoxy-1-[methyl(nonanoyl)amino]-D-glucitol

C16H33NO6 (335.2307758)


   

(3R,4S)-1-tert-butoxycarbonyl-3-(2-ethoxyethoxy)-4-phenyl-2-azetidione

(3R,4S)-1-tert-butoxycarbonyl-3-(2-ethoxyethoxy)-4-phenyl-2-azetidione

C18H25NO5 (335.173264)


   

N-(ADAMANTAN-2-YL)-2-(NAPHTHALEN-2-YLOXY)ACETAMIDE

N-(ADAMANTAN-2-YL)-2-(NAPHTHALEN-2-YLOXY)ACETAMIDE

C22H25NO2 (335.188519)


   

(4-BENZYLOXY-3-METHOXY-BENZYL)-HYDRAZINE

(4-BENZYLOXY-3-METHOXY-BENZYL)-HYDRAZINE

C17H25N3O4 (335.184497)


   

1-BOC-4-(CARBOXY-PYRIDIN-4-YL-METHYL)-[1,4]DIAZEPANE

1-BOC-4-(CARBOXY-PYRIDIN-4-YL-METHYL)-[1,4]DIAZEPANE

C17H25N3O4 (335.184497)


   

azanium,2-methylidenehexanoic acid,2-methylprop-2-enoate,styrene

azanium,2-methylidenehexanoic acid,2-methylprop-2-enoate,styrene

C19H29NO4 (335.20964740000005)


   

1-BOC-4-(CARBOXY-PYRIDIN-3-YL-METHYL)-[1,4]DIAZEPANE

1-BOC-4-(CARBOXY-PYRIDIN-3-YL-METHYL)-[1,4]DIAZEPANE

C17H25N3O4 (335.184497)


   

3-BROMOBENZYLSULFONYLCHLORIDE

3-BROMOBENZYLSULFONYLCHLORIDE

C17H25N3O4 (335.184497)


   

1-NITRO-2-(TETRADECYLOXY)BENZENE

1-NITRO-2-(TETRADECYLOXY)BENZENE

C20H33NO3 (335.2460308000001)


   
   

Benzoic acid,2-[[2-(phenylmethylene)heptylidene]amino]-, methyl ester

Benzoic acid,2-[[2-(phenylmethylene)heptylidene]amino]-, methyl ester

C22H25NO2 (335.188519)


   

N-(2,2-DIMETHOXY-ETHYL)-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

N-(2,2-DIMETHOXY-ETHYL)-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

C17H26BNO5 (335.1903936)


   

dl-leucyl-glycyl-dl-phenylalanine

dl-leucyl-glycyl-dl-phenylalanine

C17H25N3O4 (335.184497)


   
   

3-phenyl-1-(6,7,8,9-tetrahydrobenzo[g][1,3]benzodioxol-6-ylmethyl)pyrrolidine

3-phenyl-1-(6,7,8,9-tetrahydrobenzo[g][1,3]benzodioxol-6-ylmethyl)pyrrolidine

C22H25NO2 (335.188519)


   

Boc-(S)-3-Amino-4-(4-tert-butylphenyl)butyric Acid

Boc-(S)-3-Amino-4-(4-tert-butylphenyl)butyric Acid

C19H29NO4 (335.20964740000005)


   

Methyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2 -yl}butanoate

Methyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2 -yl}butanoate

C17H25N3O4 (335.184497)


   

azanium,butyl prop-2-enoate,2-methylprop-2-enoate,styrene

azanium,butyl prop-2-enoate,2-methylprop-2-enoate,styrene

C19H29NO4 (335.20964740000005)


   

D-erythro-Sphingosine hydrochloride

D-erythro-Sphingosine hydrochloride

C18H38ClNO2 (335.2590918)


D-erythro-Sphingosine (Erythrosphingosine) hydrochloride is a specific TRPM3 activator. D-erythro-Sphingosine also induces retinoblastoma protein dephosphorylation[1][2].

   

4-(5-ETHOXYCARBONYL-PYRIDIN-2-YL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(5-ETHOXYCARBONYL-PYRIDIN-2-YL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H25N3O4 (335.184497)


   
   

tert-Butyl 4-(2-nitrobenzylamino)piperidine-1-carboxylate

tert-Butyl 4-(2-nitrobenzylamino)piperidine-1-carboxylate

C17H25N3O4 (335.184497)


   

oxeladin

oxeladin

C20H33NO3 (335.2460308000001)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents

   
   

Ontazolast

N-[(1S)-2-Cyclohexyl-1-(2-pyridinyl)ethyl]-5-methyl-1,3-benzoxazo l-2-amine

C21H25N3O (335.199752)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent

   

sodium N-methyl-N-(1-oxotetradecyl)-beta-alaninate

sodium N-methyl-N-(1-oxotetradecyl)-beta-alaninate

C18H34NNaO3 (335.24362540000004)


   

Boc-(R)-3-AMino-4-(4-tert-butyl-phenyl)-butyric acid

Boc-(R)-3-AMino-4-(4-tert-butyl-phenyl)-butyric acid

C19H29NO4 (335.20964740000005)


   

(S)-5-[(Biphenyl-4-yl)methyl]-1-(2,2-dimethylpropionyl)pyrrolidin-2-one

(S)-5-[(Biphenyl-4-yl)methyl]-1-(2,2-dimethylpropionyl)pyrrolidin-2-one

C22H25NO2 (335.188519)


   

Valsartan EP impurity 7

Valsartan EP impurity 7

C19H21N5O (335.1746016)


   

4-(3-(tert-butoxycarbonyl(cyclopropyl)aMino)propoxy)phenylboronic acid

4-(3-(tert-butoxycarbonyl(cyclopropyl)aMino)propoxy)phenylboronic acid

C17H26BNO5 (335.1903936)


   

4-(4,4-Difluoro-1,3,5,7-tetraMethyl-4-bora-3a,4a-diaza-s-indacene-8-yl)-butyric Acid

4-(4,4-Difluoro-1,3,5,7-tetraMethyl-4-bora-3a,4a-diaza-s-indacene-8-yl)-butyric Acid

C17H22BF2N2O2 (335.1742306)


   
   

9-(2-ETHYLHEXYL)CARBAZOLE-3 6-DICARBOXA&

9-(2-ETHYLHEXYL)CARBAZOLE-3 6-DICARBOXA&

C22H25NO2 (335.188519)


   
   
   

4-CYANOPHENYL 4-OCTYLBENZOATE

4-CYANOPHENYL 4-OCTYLBENZOATE

C22H25NO2 (335.188519)


   

tert-Butyl 4-(((2-nitrophenyl)amino)methyl)piperidine-1-carboxylate

tert-Butyl 4-(((2-nitrophenyl)amino)methyl)piperidine-1-carboxylate

C17H25N3O4 (335.184497)


   

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate

C18H30BNO4 (335.226777)


   

N-(4,4-Diphenyl-3-butenyl)nipecotic acid

N-(4,4-Diphenyl-3-butenyl)nipecotic acid

C22H25NO2 (335.188519)


D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D018377 - Neurotransmitter Agents > D018682 - GABA Agents

   

GLYCYL-leucyl-phenylalanine

GLYCYL-leucyl-phenylalanine

C17H25N3O4 (335.184497)


   

N-tetradecanoyltaurine

N-tetradecanoyltaurine

C16H33NO4S (335.21301780000005)


A fatty acid-taurine conjugate derived from tetradecanoic acid.

   

4-Ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

4-Ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

C18H25NO5 (335.173264)


   
   

(2S)-2-[[2-[[(2S)-2-amino-4-methylpentanoyl]amino]acetyl]amino]-3-phenylpropanoic acid

(2S)-2-[[2-[[(2S)-2-amino-4-methylpentanoyl]amino]acetyl]amino]-3-phenylpropanoic acid

C17H25N3O4 (335.184497)


   

6-(4-benzylpiperidin-1-yl)-N-cyclopropylpyridine-3-carboxamide

6-(4-benzylpiperidin-1-yl)-N-cyclopropylpyridine-3-carboxamide

C21H25N3O (335.199752)


   

(3r,4s)-1-[(4-Amino-5h-Pyrrolo[3,2-D]pyrimidin-7-Yl)methyl]-4-[(Butylsulfanyl)methyl]pyrrolidin-3-Ol

(3r,4s)-1-[(4-Amino-5h-Pyrrolo[3,2-D]pyrimidin-7-Yl)methyl]-4-[(Butylsulfanyl)methyl]pyrrolidin-3-Ol

C16H25N5OS (335.177972)


   

2,6,8-Trimethyl-3-amino-9-benzyl-9-methoxynonanoic acid

2,6,8-Trimethyl-3-amino-9-benzyl-9-methoxynonanoic acid

C20H33NO3 (335.2460308000001)


   

Bis(5-amidino-benzimidazolyl)methane

Bis(5-amidino-benzimidazolyl)methane

C17H19N8+3 (335.1732594)


   

Myristyltrimethylammonium bromide

Tetradecyltrimethylammonium bromide

C17H38BrN (335.2187448)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AJ - Quaternary ammonium compounds D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AC - Medicated shampoos C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents

   

2-(4-Methoxyphenyl)-1-(1-pentylindol-3-YL)ethanone

2-(4-Methoxyphenyl)-1-(1-pentylindol-3-YL)ethanone

C22H25NO2 (335.188519)


   

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

C22H25NO2 (335.188519)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

leukotriene B4(1-)

leukotriene B4(1-)

C20H31O4- (335.2222226)


The leukotriene anion that is the conjugate base of leukotriene B4 arising from deprotonation of the carboxylic acid function.

   
   

(5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoate

(5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,10E,12S,14Z)-12-Hydroperoxyicosa-5,8,10,14-tetraenoate

(5Z,8Z,10E,12S,14Z)-12-Hydroperoxyicosa-5,8,10,14-tetraenoate

C20H31O4- (335.2222226)


   

15(S)-Hpete(1-)

15(S)-Hpete(1-)

C20H31O4- (335.2222226)


Conjugate base of 15(S)-HPETE arising from deprotonation of the carboxylic acid function.

   

(5Z,9E,14Z)-(8XI,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate

(5Z,9E,14Z)-(8XI,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate

C20H31O4- (335.2222226)


Conjugate base of (5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoic acid arising from deprotonation of the carboxylic acid function.

   

(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyicosa-5,9,11,14-tetraenoate

(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyicosa-5,9,11,14-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8R,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate

(5Z,8R,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,10E,12R,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate

(5Z,8Z,10E,12R,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate

C20H31O4- (335.2222226)


   

15(R)-Hpete(1-)

15(R)-Hpete(1-)

C20H31O4- (335.2222226)


A hydroperoxy fatty acid anion that is the conjugate base of 15(R)-HPETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoate

(8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoate

C20H31O4- (335.2222226)


An unsaturated fatty acid anion that is the conjugate base of (8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoate

(8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoate

C20H31O4- (335.2222226)


An unsaturated fatty acid anion that is the conjugate base of (8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoate

(10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoate

C20H31O4- (335.2222226)


An unsaturated fatty acid anion that is the conjugate base of (10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-Oate

(13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-Oate

C20H31O4- (335.2222226)


   

(1R,4Z,6R,7R)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

(1R,4Z,6R,7R)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

C18H25NO5 (335.173264)


   

Strychnine(1+)

Strychnine(1+)

C21H23N2O2+ (335.17594379999997)


An indole alkaloid cation obtained by protonation of the tertiary amino group of strychnine.

   

[(4S)-4-cyano-5-methyl-4-phenylhexyl]-methyl-(2-phenylethyl)azanium

[(4S)-4-cyano-5-methyl-4-phenylhexyl]-methyl-(2-phenylethyl)azanium

C23H31N2+ (335.2487106)


   

7-[(1R,2S)-2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoate

7-[(1R,2S)-2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoate

C20H31O4- (335.2222226)


   

(13E)-(15S)-15-Hydroxy-9-oxoprosta-11,13-dienoate

(13E)-(15S)-15-Hydroxy-9-oxoprosta-11,13-dienoate

C20H31O4- (335.2222226)


   

(5Z,8Z,14Z)-(11R,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoate

(5Z,8Z,14Z)-(11R,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoate

C20H31O4- (335.2222226)


   

(5S,7E,9E,11Z,13E,15S)-5,15-dihydroxyicosa-7,9,11,13-tetraenoate

(5S,7E,9E,11Z,13E,15S)-5,15-dihydroxyicosa-7,9,11,13-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,11Z,14Z)-(8S,9S,10R)-10-hydroxy-8,9-epoxyicosa-5,11,14-trienoate

(5Z,11Z,14Z)-(8S,9S,10R)-10-hydroxy-8,9-epoxyicosa-5,11,14-trienoate

C20H31O4- (335.2222226)


   

Pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl(1,6)dioxacyclododecino(2,3,4-gh)-

Pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl(1,6)dioxacyclododecino(2,3,4-gh)-

C18H25NO5 (335.173264)


D000970 - Antineoplastic Agents

   

Neo-triangularine

Neo-triangularine

C18H25NO5 (335.173264)


   

prostaglandin A1(1-)

prostaglandin A1(1-)

C20H31O4- (335.2222226)


Conjugate base of prostaglandin A1.

   

(5as,12as,13as)-12,12-Dimethyl-2,3,11,12,12a,13-Hexahydro-1h,5h,6h-5a,13a-(Epiminomethano)indolizino[7,6-B]carbazol-14-One

(5as,12as,13as)-12,12-Dimethyl-2,3,11,12,12a,13-Hexahydro-1h,5h,6h-5a,13a-(Epiminomethano)indolizino[7,6-B]carbazol-14-One

C21H25N3O (335.199752)


   
   

Prostaglandin C1(1-)

Prostaglandin C1(1-)

C20H31O4- (335.2222226)


Conjugate base of prostaglandin C1.

   

5-Hpete(1-)

5-Hpete(1-)

C20H31O4- (335.2222226)


A HPETE anion that is the conjugate base of 5-HPETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

15-Hpete(1-)

15-Hpete(1-)

C20H31O4- (335.2222226)


A HPETE anion that is the conjugate base of 15-HPETE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

5(S),15(S)-DiHETE(1-)

5(S),15(S)-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 5(S),15(S)-DiHETE, arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

5(S),11(R)-DiHETE(1-)

5(S),11(R)-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 5(S),11(R)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

5(S),15(R)-DiHETE(1-)

5(S),15(R)-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 5(S),15(R)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

4-[3-(4-Methoxyanilino)-3-oxopropyl]-1-piperazinecarboxylic acid ethyl ester

4-[3-(4-Methoxyanilino)-3-oxopropyl]-1-piperazinecarboxylic acid ethyl ester

C17H25N3O4 (335.184497)


   
   
   
   

hepoxilin A3(1-)

hepoxilin A3(1-)

C20H31O4- (335.2222226)


A hepoxilin anion that is the conjugate base of hepoxilin A3, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

hepoxilin B3(1-)

hepoxilin B3(1-)

C20H31O4- (335.2222226)


A hepoxilin anion that is the conjugate base of hepoxilin B3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(8S)-hepoxilin A3(1-)

(8S)-hepoxilin A3(1-)

C20H31O4- (335.2222226)


A hepoxilin A3 anion that is the conjugate base of (8S)-hepoxilin A3, obtained by deprotonation of the carboxylic acid group; major species at pH 7.3.

   

6-trans-leukotriene B4(1-)

6-trans-leukotriene B4(1-)

C20H31O4- (335.2222226)


A leukotriene anion that is the conjugate base of 6-trans-leukotriene B4 arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

8,20-DiHETE(1-)

8,20-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 8,20-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

5,20-DiHETE(1-)

5,20-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 5,20-DiHETE, arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

9(R)-Hpete(1-)

9(R)-Hpete(1-)

C20H31O4- (335.2222226)


A HPETE anion obtained by deprotonation of the carboxy group of 9(R)-HPETE; major species at pH 7.3.

   

12,20-DiHETE(1-)

12,20-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 12,20-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

11(S)-hydroxy-14(S),15(S)-hepoxilin A3(1-)

11(S)-hydroxy-14(S),15(S)-hepoxilin A3(1-)

C20H31O4- (335.2222226)


An hepoxilin anion that is the conjugate base of 11(S)-hydroxy-14(S),15(S)-hepoxilin A3, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoate

(8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoate

C20H31O4- (335.2222226)


An unsaturated fatty acid anion that is the conjugate base of (8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoate

(7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoate

C20H31O4- (335.2222226)


A polyunsaturated fatty acid anion that is the conjugate base of (7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoate

(13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoate

C20H31O4- (335.2222226)


An unsaturated fatty acid anion that is the conjugate base of (13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(5Z,8Z,11R,12E,14Z)-11-hydroperoxyicosa-5,8,12,14-tetraenoate

(5Z,8Z,11R,12E,14Z)-11-hydroperoxyicosa-5,8,12,14-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,11Z,13S)-13-hydroxy-13-[(2S,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

(5Z,8Z,11Z,13S)-13-hydroxy-13-[(2S,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

C20H31O4- (335.2222226)


   
   
   
   

12-oxo-(5S)-Hydroxy-(6Z,8E,14Z)-eicosatrienoate

12-oxo-(5S)-Hydroxy-(6Z,8E,14Z)-eicosatrienoate

C20H31O4- (335.2222226)


   

(5S,6E,10E,12E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

(5S,6E,10E,12E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,11Z)-13-[3-(5-hydroxypentyl)oxiran-2-yl]trideca-5,8,11-trienoate

(5Z,8Z,11Z)-13-[3-(5-hydroxypentyl)oxiran-2-yl]trideca-5,8,11-trienoate

C20H31O4- (335.2222226)


   

(S)-3-{[2-(1,1-dimethylallyl)-indol-3-yl]methyl}-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one

(S)-3-{[2-(1,1-dimethylallyl)-indol-3-yl]methyl}-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one

C21H25N3O (335.199752)


   

(5Z,8S,9E,11Z,13E,15S)-8,15-dihydroxyicosa-5,9,11,13-tetraenoate

(5Z,8S,9E,11Z,13E,15S)-8,15-dihydroxyicosa-5,9,11,13-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,11Z)-13-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

(5Z,8Z,11Z)-13-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

C20H31O4- (335.2222226)


   

(5Z)-7-{3-[(2Z,5Z)-11-hydroxyundeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoate

(5Z)-7-{3-[(2Z,5Z)-11-hydroxyundeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoate

C20H31O4- (335.2222226)


   

(5Z,8Z)-10-{3-[(2Z)-8-hydroxyoct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoate

(5Z,8Z)-10-{3-[(2Z)-8-hydroxyoct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoate

C20H31O4- (335.2222226)


   

(5S,6R,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

(5S,6R,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

C20H31O4- (335.2222226)


   
   
   
   
   
   
   
   
   

(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   
   
   
   
   
   

(5Z,8Z,10E,12E,14R,15S)-14,15-dihydroxyicosa-5,8,10,12-tetraenoate

(5Z,8Z,10E,12E,14R,15S)-14,15-dihydroxyicosa-5,8,10,12-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,11Z)-13-hydroxy-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoate

(5Z,8Z,11Z)-13-hydroxy-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoate

C20H31O4- (335.2222226)


   
   

(5Z,8Z,12E)-11-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,12-trienoate

(5Z,8Z,12E)-11-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,12-trienoate

C20H31O4- (335.2222226)


   

4-{3-[(2Z,5Z,8Z)-14-hydroxytetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoate

4-{3-[(2Z,5Z,8Z)-14-hydroxytetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoate

C20H31O4- (335.2222226)


   

(5S,6S,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

(5S,6S,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

C20H31O4- (335.2222226)


   

2-(1,1-Dimethyl-2-propenyl)-3-(1-hydroxy-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-3-ylmethyl)-1H-indole

2-(1,1-Dimethyl-2-propenyl)-3-(1-hydroxy-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-3-ylmethyl)-1H-indole

C21H25N3O (335.199752)


   
   

6-Methoxy-3-methyl-9-[2-(6-methylpyridin-3-yl)ethyl]-1,2,3,4-tetrahydro-gamma-carboline

6-Methoxy-3-methyl-9-[2-(6-methylpyridin-3-yl)ethyl]-1,2,3,4-tetrahydro-gamma-carboline

C21H25N3O (335.199752)


   

MTAB

Tetradecyltrimethylammonium bromide

C17H38N. Br (335.2187448)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AJ - Quaternary ammonium compounds D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AC - Medicated shampoos C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents Same as: D02164

   

3-[Dodecyl(dimethyl)ammonio]-1-propanesulfonate

N-Dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate

C17H37NO3S (335.2494012)


D013501 - Surface-Active Agents > D003902 - Detergents

   

5(S)-HPETE(1-)

5(S)-HPETE(1-)

C20H31O4 (335.2222226)


Conjugate base of 5(S)-HPETE arising from deprotonation of the carboxylic acid function.

   

8(R)-HPETE(1-)

8(R)-HPETE(1-)

C20H31O4 (335.2222226)


Conjugate base of 8(R)-HPETE arising from deprotonation of the carboxylic acid function.

   

N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide

N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide

C22H25NO2 (335.188519)


   

9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate

9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate

C20H31O4 (335.2222226)


   

11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate

11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate

C20H31O4 (335.2222226)


   

8(S),15(S)-DiHETE(1-)

8(S),15(S)-DiHETE(1-)

C20H31O4 (335.2222226)


A DiHETE(1-) that is the conjugate base of 8(S),15(S)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

8(S)-HPETE(1-)

8(S)-HPETE(1-)

C20H31O4 (335.2222226)


A HPETE anion obtained by deprotonation of the carboxy group of (8S)-HPETE.

   

14(R),15(S)-DiHETE(1-)

14(R),15(S)-DiHETE(1-)

C20H31O4 (335.2222226)


A DiHETE(1-) that is the conjugate base of 14(R),15(S)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

11 hydroxy-(14R,15S)-epoxy-(5Z,8Z,12E)-icosatrienoate

11 hydroxy-(14R,15S)-epoxy-(5Z,8Z,12E)-icosatrienoate

C20H31O4 (335.2222226)


An epoxy(hydroxy)icosatrienoate that is the conjugate base of 11 hydroxy-(14R,15S)-epoxy-(5Z,8Z,12E)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

12(R)-HPETE(1-)

12(R)-HPETE(1-)

C20H31O4 (335.2222226)


A hydroperoxy fatty acid anion that is the conjugate base of 12(R)-HPETE, obtained by deprotonation of the carboxy group.

   

(13S)-hydroxy-(14S,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoate

(13S)-hydroxy-(14S,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoate

C20H31O4 (335.2222226)


A 13-hydroxy-14,15-epoxy-(5Z,8Z,11Z)-icosatrienoate that is the conjugate base of 13(S)-hydroxy-(14S,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

13-hydroxy-(14R,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoate(1-)

13-hydroxy-(14R,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoate(1-)

C20H31O4 (335.2222226)


A 13-hydroxy-14,15-epoxy-(5Z,8Z,11Z)-icosatrienoate that is the conjugate base of 13-hydroxy-(14R,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin B1(1-)

prostaglandin B1(1-)

C20H31O4 (335.2222226)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin B1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

12(S)-HPETE(1-)

12(S)-HPETE(1-)

C20H31O4 (335.2222226)


Conjugate base of 12(S)-HPETE arising from deprotonation of the carboxylic acid function.

   

11(R)-HPETE(1-)

11(R)-HPETE(1-)

C20H31O4 (335.2222226)


A hydroperoxy fatty acid anion that is the conjugate base of 11(R)-HPETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

AcCa(12:4)

AcCa(12:4)

C19H29NO4 (335.20964740000005)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   

PPARγ-IN-2

PPARγ-IN-2

C19H21N5O (335.1746016)


PPARγ-IN-2 (Compound 5a) is a PPARγ inhibitor. PPARγ-IN-2 inhibits TG accumulation in 3T3-L1 preadipocytes (EC50: 0.106 μM). PPARγ-IN-2 inhibits high-cholesterol diet (HFC)-induced obesity and related metabolic syndrome, and reduces lipid accumulation in adipose tissue[1].

   

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-8-carboxylic acid

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-8-carboxylic acid

C17H25N3O4 (335.184497)


   

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1z,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1z,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

C20H33NO3 (335.2460308000001)


   

(1r,4e,6s,7r,17s)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(1r,4e,6s,7r,17s)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H25NO5 (335.173264)


   

(1'r,2r,4s,4'r,7's)-4-methyl-4'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-11'-oxa-5'-azaspiro[oxolane-2,10'-tricyclo[5.3.1.0¹,⁵]undecan]-5-one

(1'r,2r,4s,4'r,7's)-4-methyl-4'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-11'-oxa-5'-azaspiro[oxolane-2,10'-tricyclo[5.3.1.0¹,⁵]undecan]-5-one

C18H25NO5 (335.173264)


   

(1s,13s,15s)-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s)-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C21H25N3O (335.199752)


   

5-{5-[(acetyloxy)methyl]-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl}-2-methyl-4-oxopent-2-enimidic acid

5-{5-[(acetyloxy)methyl]-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl}-2-methyl-4-oxopent-2-enimidic acid

C18H25NO5 (335.173264)


   

(1r,4r,5s)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-hexyl-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

(1r,4r,5s)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-hexyl-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C19H29NO4 (335.20964740000005)


   

(1r,4e,7r,11s,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

(1r,4e,7r,11s,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

C18H25NO5 (335.173264)


   

(4e)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(4e)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H25NO5 (335.173264)


   

3,7-dimethoxy-2-methyl-5-octyl-5,6,7,8-tetrahydro-1h-quinolin-4-one

3,7-dimethoxy-2-methyl-5-octyl-5,6,7,8-tetrahydro-1h-quinolin-4-one

C20H33NO3 (335.2460308000001)